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Abstract
Leukemia is known as the world’s fifth most prevalent cancer. 
New cytotoxic drugs have created considerable progress in the 
treatment, but side effects are still the important cause of mortality. 
Plant derivatives have been recently considered as important 
sources for the treatment of various diseases, including cancer. 
Gallic acid (GA) is a polyhydroxyphenolic compound with a 
wide range of biological functions. The aim of the present study 
was to evaluate the effect of GA on proliferation inhibition and 
apoptosis induction of a lymphoblastic leukemia cell line. Jurkat 
cell (C121) line was cultured in RPMI 1640 supplemented with 
10% heat-inactivated fetal bovine serum (FBS) with different 
concentrations of GA (10, 20, 30, 40, 50, 60, 70, 80, 90, and 
100 μM) for 24, 48 and 72 hours. The effect of GA on cell 
viability was measured using MTS assay. Induction of apoptosis 
was evaluated with Annexin V-FITC/PI kit and flow cytometry. 
Data were analyzed by SPSS version 20 using Kruskal-Wallis 
and Dunn’s multiple comparison tests. Decline of cell viability 
to less than 50% was observed at 60.3±1.6, 50.9±1.5, and 
30.9±2.8 μM concentration after 24, 48, and 72 hours incubation, 
respectively. All concentrations of GA (10, 30, 50 and 80 μM) 
enhanced apoptosis compared to the control (P<0.05). The 
results demonstrate that the polyphenolic compound, GA, is 
effective in inhibition of proliferation and induction of apoptosis 
in Jurkat cell line. It is recommended to study the mechanism of 
apoptosis induction in future investigations.
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Introduction
T-cell acute lymphoblastic leukemia (T-ALL) is a neoplastic 
disturbance of the lymphoblast devoted to the T-cell line.1 Acute 
lymphoblastic leukemia (ALL) is the most common malignancy of 
infantile. The majority (about 80%) of infantile leukemia cases is 
ALL and it is usually more prevalent in males than females.2
Plants are an important source of natural products and have a 
wide variety of structural and biological attributes. They have played 
a significant role in traditional medicine of various countries.Plant 
derivatives have been recently considered as important sources 
for the treatment of various diseases, including cancer.3 Induction 
of apoptosis in cells is one of the targets of anti-cancer therapy.4
What’s Known
• Gallic acid (GA) and its analogs 
reportedly have many biological 
activities, including antioxidant, 
antimutagenic, and anticarcinogenic.
• Major interest in GA and its analogs 
is related to its antitumor activity.
• GA-induced apoptosis is 
associated with oxidative stress.
• Anticancer activity of GA has been 
reported in some cancer cell lines such 
as prostate, lung, gastric, colon, breast, 
cervical, and esophageal cancer.
What’s New
• GA can inhibit the proliferation and 
induction of apoptosis in a lymphoblastic 
leukemia Jurkat cell line.
• Effect of GA on the Jurkat cell line 
is dose- and time-dependent.
• IC50 of GA on Jurkat cells was 
50.9 ± 1.5 after 48 hours’ incubation 
time, which is slightly different from 
other cell lines.
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Gallic acid (GA) is a polyhydroxyphenolic 
compound (figure 1) which is widely distributed 
in natural plants, fruits, and food as well as 
having a wide range of biological functions.5 
Many foods such as gallnuts, sumac, grape, 
green tea, oak bark, strawberry, lemon, banana, 
pineapple, witch hazel, and apple peel are known 
to be rich in GA.6 This polyhydroxyphenolic 
compound has been seen in human blood 
plasma after intake of GA-rich food.GA and 
its analogs have been reported to have many 
biological activities, including antioxidant, anti-
tumor, anti-mutagenic, and anti-carcinogenic.6 
However, the main interest in gallic acid and its 
analogs is related to its antitumor activity. It has 
been shown that propyl, lauryl, methyl gallate 
induces apoptosis and inhibits proliferation 
in tumor cell lines.7 GA-induced apoptosis is 
associated with oxidative stress.6 However, 
GA showed no cytotoxicity against endothelial 
cells and usual fibroblast.8 Some studies have 
shown that GA causes DNA fragmentation7 and 
is also responsible for the suppression of tumor 
angiogenesis, leading to inhibition of tumor 
metastasis.9 In fact, anti-cancer activity of GA 
has been reported in various cancer cells, such 
as prostate, lung, gastric, colon, breast, cervical 
and esophageal cancer.10
In the absence of any reports on the effect 
of GA on lymphoblastic leukemia cell line, 
we aimed to evaluate the effect of GA on 
proliferation inhibition and apoptosis induction 
of this cell line.
Materials and Methods
Reagents
Jurkat cells were purchased from Pasteur 
Institute (Iran). RPMI 1640 medium, pen/strep, 
trypan blue, GA, and MTS were obtained from 
Sigma-Aldrich (Germany). Fetus bovine serum 
(FBS) was from GIBCO (USA) and Annexin 
V-FITC/PI apoptosis kit from BD (USA).
Cell Culture and Treatment
Lymphoblastic leukemia cell line 
(Jurkat cell (C121)) was cultured in RPMI 
1640 supplemented with 10% heat-inactivated 
fetal bovine serum (FBS), 100 IU/mL penicillin, 
0.1 mg/mL streptomycin (PS) and 0.3 mg/ml 
L-glutamine. The cells were incubated at 37°C in 
a humidified incubator with 5% carbon dioxide. 
The cells were maintained at the concentration 
of 2×105 per ml and then were transferred to 
96 and/or 6-well plates for experiments. To 
determine viable cells, the culture was harvested 
and the cells were counted by the trypan blue 
staining and a standard hemocytometer. Different 
concentrations (μM) of GA were prepared in the 
RPMI 1640 medium and untreated cells were 
considered as a control group.
Jurkat Cell Growth Curve
Jurkat cells were cultured in a 24-well plate 
between passages 5-7 at a concentration of 
2×105 per well. The culture medium was replaced 
every 3 days and the cell growth rate was 
calculated for each triplicate wells using trypan 
blue and counting live cells every 24 hours for 
8 days (192 h).
Assessment of Cell Viability by MTS Assay
This chromogenic assay involves biological 




Briefly, Jurkat cells were seeded in the 
above complete media (at the concentration 
of 1×104 cells per well in 96-well plates) and 
allowed to grow overnight. Cells were treated 
with different concentrations (10-100 μM) of GA. 
After incubation for 48 h, 20 μl of MTS (5 mg/
mL in phosphate buffered saline) was added 
to each well and incubated for 3 hours in the 
darkness. The absorbance was measured at 
490-620 nm by an ELISA reader (Stat Fax 2100, 
Awareness).
Annexin V-FITC/PI Flow Cytometric Analysis
Apoptosis was measured using Annexin 
V-FITC/PI kit and flow cytometry analysis 
according to manufacturer’s instruction. Jurkat 
cells (2×105) were cultured in 6-well plates for 
24 hours and treated with different concentrations 
of GA (10, 30, 50, and 80 μM) for 48 h. The cells 
were then washed twice in PBS and resuspended 
in 100 μl binding buffer. The cells were added 
to 10 μl of PI and 2 μl of Annexin V-FITC and 
incubated for 20 minutes in the darkness. The 
cells were then analyzed by flow cytometry.
Figure 1: Gallic acid chemical structure.
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Statistical Analysis
Data from at least three independent 
experiments are presented as the mean±SD 
(standard deviation) and were analyzed by 
SPSS version 20 using Kruskal-Wallis and 
Dunn’s multiple comparison tests. The difference 
was considered significant if P<0.05. IC50 was 
obtained from Probit analysis.
Results
Cell Growth Curve
The number of cells increased in the first 24 h 
after passage. From 24 to 120 h, Jurkat cells 
showed normal exponential growth and then 
entered stationary phase. As shown in figure 2, 
the peak growth rate of the cells occurred on 
the fifth day and they entered death phase after 
168 h.
Decrease in Cell Viability by GA
The data obtained from the absorption at 490 nm 
was converted into percentages. The results 
showed a dose- and time-dependent behavior 
(figure 3). Cell viability was about 93%, 87%, 
and 65% at a concentration of 20 μM after 24, 
48 and 72 hours, respectively. However, viability 
declined to 13%, 8%, and 5% at a concentration 
of 100 μM after the above incubation periods. 
IC50 (inhibition concentration) was 60.3±1.6 μM, 
50.9±1.5 μM and 30.9±2.8 μM after a period of 
24, 48 and 72 hours, respectively (figure 4).
Induction of Apoptosis
Apoptosis was induced by GA as described in 
the “materials and methods” section. The Annexin 
V positive cells show the apoptosis (figure 5A) 
and the percentages of apoptotic cells increased 
markedly in GA treated cells compared with the 
control group (without treatment) (figure 5B). 
The mean of apoptosis was 25%, 35%, 50%, 
and 86% at the concentration of 10, 30, 50, and 
80 μM, respectively, compared to 3.80% in the 
control group.
Discussion
New cytotoxic drugs have made considerable 
progress in the treatment but side effects such 
as heart and kidney problems, suppression of the 
immune and hematopoietic systems are still the 
important causes of mortality.3 Several studies 
have shown the anti-cancer activity of GA, inhibition 
of proliferation, and induction of apoptosis in some 
tumor cell lines.7 It has also been reported that GA 
induces apoptosis in cancer cells (TE2) but not in 
non-cancerous cells with the same origin.11 In the 
process of cancer development, existed mutations 
allow cells to dispose of apoptosis; therefore, 
Figure 2: Growth curves of Jurkat cells during 8 days. The 
growth curve shows exponential growth phase at 24-120 h, 
stationary phase at 120-144 h, and death phase after 168 h. 
The peak growth rate of the cells is on the fifth day.
Figure 3: A) Decreased cell viability in the presence of 50 μM concentration of GA after 24, 48 and 72 hours (time-dependent). 
B) Decreased cell viability in Jurkat cells incubated with various concentrations (0, 20, 40, and 80) after 48 hours (dose-dependent) 
(magnification 40x).
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induction of apoptosis could be an approach for 
prevention and treatment.12
The results of our study showed that GA in 
a dose- and time-dependent manner decreased 
cell viability and increased the induction of 
apoptosis in Jurkat cells. The results showed that 
GA caused a remarkable decrease in the cell 
growth in 72 hours and an IC50 of about 60 μM 
in 24 h, about 50 μM in 48 h and about 30 μM in 
72 h. We found the concentration of drug that was 
associated with a high percentage of apoptosis 
by flow cytometry analysis caused a significant 
decrease in cell viability in the MTS assay.
GA inhibitory effect on cell proliferation has 
been studied in several cancer cell lines in 
various studies. Larry et al. showed that GA could 
induce apoptosis depending on reactive oxygen 
species (ROS) in prostate cancer cells. In their 
study, 80 μg/ml GA has induced the maximum 
inhibitory effect in 24 hours, which is slightly higher 
than our finding. The cells showed the activation 
of caspases 3, 8, and 9. They also found that cells 
could be protected against GA cytotoxicity when 
pretreated with increasing levels of superoxide 
dismutase/catalase mixture, NAC, or GSH.13 The 
ROS-dependent apoptotic mechanism of GA 
killed these malignant cells effectively.
You et al. studied the effect of GA in two types 
of lung cancer cells (A549 and Calu-6). The 
drug inhibits the growth of lung cancer cells and 
induces cell death, which is related to glutathione 
depletion as well as ROS level changes.14 
As GA may affect various cells differently, the 
mechanism of cell death and the required dose 
could be varied.
Lu et al. studied the anti-proliferative, anti-
invasion, and angiogenesis and induction of 
cell death by GA in human glioma cells. They 
showed that the inhibition of cell viability by GA 
is dose-dependent, which is consistent with our 
data.9
Chia et al. studied the anticancer effects 
of GA in oral cancer cell lines including UM1, 
UM2, SCC-4, and SEC-9. They showed that the 
required concentration and the time of exposure 
of GA for the induction of apoptosis are different 
in various cell lines. The compound caused 
cell death at 48 hours in SCC-4, SCC-9, and 
UM1 cells, but not in UM2 cells.15 This finding 
can be explained by the fact that different 
pathways of apoptosis may cooperate in 
different cells as it has been reported in different 
studies.16 It is well known that apoptosis plays 
an important role in responses to chemotherapy 
agents and can be activated through extrinsic 
and intrinsic pathways. It is proposed that in 
a type of melanoma cell line (A375.S2), GA 
triggers apoptosis through the regulation of FAS/
FASL, Bax, BCL2, and through the activation of 
caspase cascade.16
Figure 4: Jurkat cell viability by MTS assay. Cells were 
treated with different concentrations of GA; 0 (control), 
10, 20, 30, 40, 50, 60, 70, 80, 90 and 100 μM. Cell viability 
was determined by measuring the mitochondrial metabolism 
of MTS after 24, 48 and 72 h. IC50 was 60.3±1.6 μM in 24 h, 
50.9±1.5 μM in 48 h and 30.9±2.8 μM in 72 h. Data are 
presented as mean±SD. 
Figure 5: Flow cytometric analysis of cell apoptosis. Cells were cultured for 48 h and then treated with different concentrations of 
GA for 48 h. The cell apoptosis was detected by flow cytometry using Annexin V-FITC/PI staining. A) An example of flow cytometric 
analysis of cell apoptosis. Cells were treated with 50 μM of GA. The apoptosis was observed in 50.73% of treated cells compared 
to 3.80% in control. B) The rate of apoptosis at different concentrations of GA was compared to the control. Each data shows the 
mean of three independent experiments (P=0.009).
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You et al. studied the effect of GA in Hela 
cervical cancer cells. They showed that GA 
inhibits the growth of Hela cells and induces 
apoptosis and GA-induced Hela cell death is 
accompanied by ROS increase and glutathione 
depletion.6 Hwang et al. showed that GA exerts 
a strong antiproliferative activity against breast 
cancer cells.17
Our results from flow cytometric assays 
indicated that the apoptosis in Jurkat cells is 
dose-dependent and about 80% apoptosis was 
observed after 48 hours in the treatment with 
80 μM concentration. This value is higher than 
that found in HL-60 promyelocytic leukemia 
cells.18 GA has demonstrated early apoptosis 
in some oral squamous carcinoma cell lines 
and late apoptosis in some others.15 The effect 
ofGA on the ratio of pro-apoptotic/anti-apoptotic 
molecules and signaling pathways in Jurkat cells 
need to be investigated. Anti-proliferative effect 
of GA is not just by the induction of apoptosis 
through the classic pathways, since some 
studies have reported delays in DNA repair and 
cell cycle arrest. Human prostate PC3 cells after 
exposure to GA, have demonstrated a decrease 
of cell viability in a time- and dose-dependent 
manner, more DNA damage, and also inhibition 
of the expression of P53 mRNA and other DNA 
repair genes.19 In fact, the inhibitory effect of 
cancer cell growth is mediated by the modulation 
of genes involved in cell cycle, metastasis 
angiogenesis, and apoptosis.20
Madlener et al. studied the effect of GA in 
promyelocytic leukemia cells (HL-60).18 They 
showed that apoptosis induced by GA is dose-
dependent, which is again in agreement with our 
findings. However, they found 39% apoptosis 
in the presence of 80 μM GA, which is lower 
compared to our data at the same concentration. 
This finding can be related to different origins of 
the cell line. They also found dose-dependent 
cell cycle arrest in their study. Other studies have 
demonstrated the effect of GA on gastric cancer 
cells, leukemia cells (k562) and L1210,4 which 
is consistent with our study. Although our study 
showed that GA could decrease cell viability 
and induced apoptosis in Jurkat cells, which is 
consistent with the studies of other cell lines, the 
mechanism of apoptosis may be different and 
needs to be addressed in future studies. GA might 
be a potential anti-cancer compound against 
lymphoblastic leukemia; however, these effects on 
ALL patient lymphoblasts need to be investigated.
Conclusion
It seems that the decrease in Jurkat cell numbers 
in the presence of GA was dependent on the 
level of apoptosis, which is a favorable effect of 
anti-cancer treatments. GA could be promising 
in T-ALL combination chemotherapy, but it 
needs to be investigated in other lymphoblastic 
cell lines, ALL lymphoblasts, followed by in vivo 
experimental models.
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